152 related articles for article (PubMed ID: 18719978)
21. Regulation and tissue-specific expression of δ-aminolevulinic acid synthases in non-syndromic sideroblastic anemias and porphyrias.
Peoc'h K; Nicolas G; Schmitt C; Mirmiran A; Daher R; Lefebvre T; Gouya L; Karim Z; Puy H
Mol Genet Metab; 2019 Nov; 128(3):190-197. PubMed ID: 30737140
[TBL] [Abstract][Full Text] [Related]
22. The anti-inflammatory effect of tussilagone, from Tussilago farfara, is mediated by the induction of heme oxygenase-1 in murine macrophages.
Hwangbo C; Lee HS; Park J; Choe J; Lee JH
Int Immunopharmacol; 2009 Dec; 9(13-14):1578-84. PubMed ID: 19800419
[TBL] [Abstract][Full Text] [Related]
23. Heme regulates hepatic 5-aminolevulinate synthase mRNA expression by decreasing mRNA half-life and not by altering its rate of transcription.
Hamilton JW; Bement WJ; Sinclair PR; Sinclair JF; Alcedo JA; Wetterhahn KE
Arch Biochem Biophys; 1991 Sep; 289(2):387-92. PubMed ID: 1898078
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of aminolevulinate synthase, the rate-limiting enzyme for heme biosynthesis in Alzheimer's disease.
Dwyer BE; Smith MA; Richardson SL; Perry G; Zhu X
Neurosci Lett; 2009 Aug; 460(2):180-4. PubMed ID: 19477221
[TBL] [Abstract][Full Text] [Related]
25. Regulation of human liver delta-aminolevulinic acid synthase by bile acids.
Peyer AK; Jung D; Beer M; Gnerre C; Keogh A; Stroka D; Zavolan M; Meyer UA
Hepatology; 2007 Dec; 46(6):1960-70. PubMed ID: 17975826
[TBL] [Abstract][Full Text] [Related]
26. RNAi-mediated silencing of hepatic Alas1 effectively prevents and treats the induced acute attacks in acute intermittent porphyria mice.
Yasuda M; Gan L; Chen B; Kadirvel S; Yu C; Phillips JD; New MI; Liebow A; Fitzgerald K; Querbes W; Desnick RJ
Proc Natl Acad Sci U S A; 2014 May; 111(21):7777-82. PubMed ID: 24821812
[TBL] [Abstract][Full Text] [Related]
27. Heterozygous disruption of ALAS1 in mice causes an accelerated age-dependent reduction in free heme, but not total heme, in skeletal muscle and liver.
van Wijk K; Akabane T; Kimura T; Saitoh S; Okano S; Kelly VP; Takagi M; Kodama K; Takahashi K; Tanaka T; Nakajima M; Nakajima O
Arch Biochem Biophys; 2021 Jan; 697():108721. PubMed ID: 33307066
[TBL] [Abstract][Full Text] [Related]
28. Tissue-specific expression of ALA synthase-1 and heme oxygenase-1 and their expression in livers of rats chronically exposed to ethanol.
Zheng J; Tian Q; Hou W; Watts JA; Schrum LW; Bonkovsky HL
FEBS Lett; 2008 Jun; 582(13):1829-34. PubMed ID: 18472004
[TBL] [Abstract][Full Text] [Related]
29. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on heme oxygenase-1, biliverdin IXalpha reductase and delta-aminolevulinic acid synthetase 1 in rats with wild-type or variant AH receptor.
Niittynen M; Tuomisto JT; Pohjanvirta R
Toxicology; 2008 Sep; 250(2-3):132-42. PubMed ID: 18657588
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of metalloporphyrins on messenger RNA levels of delta-aminolevulinate synthase and heme oxygenase. Studies in cultured chick embryo liver cells.
Cable EE; Pepe JA; Karamitsios NC; Lambrecht RW; Bonkovsky HL
J Clin Invest; 1994 Aug; 94(2):649-54. PubMed ID: 8040318
[TBL] [Abstract][Full Text] [Related]
31. Alterations of antioxidant enzyme expression in response to hydrogen peroxide.
Röhrdanz E; Kahl R
Free Radic Biol Med; 1998 Jan; 24(1):27-38. PubMed ID: 9436611
[TBL] [Abstract][Full Text] [Related]
32. Increased heme oxygenase-1 and decreased delta-aminolevulinate synthase expression in the liver of patients with acute liver failure.
Fujii H; Takahashi T; Matsumi M; Kaku R; Shimizu H; Yokoyama M; Ohmori E; Yagi T; Sadamori H; Tanaka N; Akagi R; Morita K
Int J Mol Med; 2004 Dec; 14(6):1001-5. PubMed ID: 15547665
[TBL] [Abstract][Full Text] [Related]
33. Drugs mediate the transcriptional activation of the 5-aminolevulinic acid synthase (ALAS1) gene via the chicken xenobiotic-sensing nuclear receptor (CXR).
Fraser DJ; Podvinec M; Kaufmann MR; Meyer UA
J Biol Chem; 2002 Sep; 277(38):34717-26. PubMed ID: 12121995
[TBL] [Abstract][Full Text] [Related]
34. In ferrochelatase-deficient protoporphyria patients, ALAS2 expression is enhanced and erythrocytic protoporphyrin concentration correlates with iron availability.
Barman-Aksözen J; Minder EI; Schubiger C; Biolcati G; Schneider-Yin X
Blood Cells Mol Dis; 2015 Jan; 54(1):71-7. PubMed ID: 25179834
[TBL] [Abstract][Full Text] [Related]
35. Hepatocyte transplantation ameliorates the metabolic abnormality in a mouse model of acute intermittent porphyria.
Yin Z; Wahlin S; Ellis EC; Harper P; Ericzon BG; Nowak G
Cell Transplant; 2014; 23(9):1153-62. PubMed ID: 23582197
[TBL] [Abstract][Full Text] [Related]
36. Liaison between heme metabolism and bioenergetics pathways-a multimodal elucidation for early diagnosis of oral cancer.
Sarkar R; Chatterjee K; Ojha D; Chakraborty B; Sengupta S; Chattopadhyay D; RoyChaudhuri C; Barui A
Photodiagnosis Photodyn Ther; 2018 Mar; 21():263-274. PubMed ID: 29307774
[TBL] [Abstract][Full Text] [Related]
37. Reciprocal effects of micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes.
Shan Y; Zheng J; Lambrecht RW; Bonkovsky HL
Gastroenterology; 2007 Oct; 133(4):1166-74. PubMed ID: 17919492
[TBL] [Abstract][Full Text] [Related]
38. Oxygen tension regulates heme oxygenase-1 gene expression in mammalian cell lines.
Takahashi S; Takahashi Y; Yoshimi T; Miura T
Cell Biochem Funct; 1998 Sep; 16(3):183-93. PubMed ID: 9747510
[TBL] [Abstract][Full Text] [Related]
39. Complex response to physiological and drug-induced hepatic heme demand in monoallelic
Vagany V; Robinson S; Chernova T; Smith AG
Mol Genet Metab Rep; 2021 Dec; 29():100818. PubMed ID: 34900592
[TBL] [Abstract][Full Text] [Related]
40. Induction of heme oxygenase-1 in human hepatocytes to protect them from ethanol-induced cytotoxicity.
Liu LG; Yan H; Zhang W; Yao P; Zhang XP; Sun XF; Nussler AK
Biomed Environ Sci; 2004 Sep; 17(3):315-26. PubMed ID: 15602829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
